Publications:

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER

Publication Date: 2023-03-16

Variant appearance in text: KMT2D: T4339P

PubMed Link: 36928921

Variant Present in the following documents:

• ccr-22-3642_supplementary_tables_1_suppts1.xlsx, sheet 3

View BVdb publication page

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.

Cancer Research And Treatment

Yoon, Sang Eun SE; Kim, Yeon Jeong YJ; Shim, Joon Ho JH; Park, Donghyun D; Cho, Junhun J; Ko, Young Hyeh YH; Park, Woong-Yang WY; Mun, Yeung-Chul YC; Lee, Kyoung Eun KE; Cho, Duck D; Kim, Won Seog WS; Kim, Seok Jin SJ

Publication Date: 2022-04

Variant appearance in text: KMT2D: T4339P

PubMed Link: 34325497

Variant Present in the following documents:

• crt-2021-752.pdf

View BVdb publication page